首页> 外文期刊>Medical Case Studies >Primary non Hodgkins lymphoma of the orbit: A case report
【24h】

Primary non Hodgkins lymphoma of the orbit: A case report

机译:原发性非霍奇金斯氏眼眶淋巴瘤1例

获取原文
       

摘要

Lymphoma is the most common malignancy of the orbit and the eyelids, accounting for 10% of malignant orbital tumors in adults. Orbital lymphomas can arise primarily in the orbit or represent a manifestation of disseminated disease. In this paper we report a case of early stage orbital lymphoma, which was managed successfully with chemotherapy, and a review of the related literature. A Moroccan Muslim woman aged 76 years, who presented a left orbital swelling. Ophthalmological examination complemented by CT has objectified orbital mass, whose biopsy was in favour of a non Hodgkin's lymphoma (NHL) large cell B. The patient was classified as stage IE after a record expansion. She was managed successfully with 6 courses of Rituximab 375 mg/m2, Cyclophosphamide 750 mg/m2 d1, Doxorubicine 50 mg/m2 d1, Vincristine 1.4 mg/m2 d1, and prednisone 50 mg/m2 d1-5 (R-CHOP) regimen, with complete response. This case highlights the important role of R-CHOP regimen for achieving successful treatment cure for patients having an early stage?orbital lymphoma.
机译:淋巴瘤是眼眶和眼睑最常见的恶性肿瘤,占成年人恶性眼眶肿瘤的10%。眼眶淋巴瘤可主要发生在眼眶或代表弥漫性疾病的表现。在本文中,我们报道了一例早期眼眶淋巴瘤,该患者已通过化学疗法成功治疗,并回顾了相关文献。一名76岁的摩洛哥穆斯林妇女,左眼眶红肿。眼科检查辅以CT扫描已明确了眼眶质量,其活检有利于非霍奇金淋巴瘤(NHL)大细胞B。该患者在记录扩大后归为IE期。通过6个疗程的利妥昔单抗375 mg / m2,环磷酰胺750 mg / m2 d1,阿霉素50 mg / m2 d1,长春新碱1.4 mg / m2 d1和泼尼松50 mg / m2 d1-5(R-CHOP)方案成功治疗了她,具有完整的响应。该病例突出了R-CHOP方案在成功治疗早期眶眶淋巴瘤患者中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号